Back
Enterprise Products Partners LP Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
70
EPD
Enterprise Products Partners LP
Last Price:
28.85
Seasonality Move:
1.78%
Sell
44
RARE
Ultragenyx Pharmaceutical
Last Price:
41.50
Seasonality Move:
-0.9%
Buy
70
Enterprise Products Partners LP (EPD)
is a Buy
Is Enterprise Products Partners LP a Buy, Sell or Hold?
- The current Enterprise Products Partners LP [EPD] share price is $29.02. The Score for EPD is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- EPD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPD Stock Price Chart
What is Enterprise Products Partners LP's stock price today?
-
The Enterprise Products Partners LP share price today is $29.02
The current trend is moderately bullish and EPD is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
EPD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 63.46 | Buy |
Chaikin Money Flow: | 898033 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.17 - 28.71) | Buy |
Bollinger Bands (100): | (27.49 - 29.13) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 49.22 | Sell |
Chaikin Money Flow: | 494801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.79 - 41.97) | Buy |
Bollinger Bands (100): | (40.81 - 48.79) | Sell |
EPD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.66 | Buy |
20-day SMA: | 28.46 | Buy |
50-day SMA: | 28.51 | Buy |
200-day SMA: | 27.55 | Buy |
8-day EMA: | 28.76 | Buy |
20-day EMA: | 28.58 | Buy |
50-day EMA: | 28.5 | Buy |
200-day EMA: | 27.7 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.2 | Buy |
20-day SMA: | 40.42 | Buy |
50-day SMA: | 41.53 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 39.89 | Buy |
20-day EMA: | 40.39 | Buy |
50-day EMA: | 41.79 | Sell |
200-day EMA: | 43.35 | Sell |
Enterprise Products Partners LP Earnings Growth & EPD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.14 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Enterprise Products Partners LP Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |